2-[2-[(3,6-dimethylcyclohexa-1,3-dien-1-yl)oxymethyl]cyclohepta-1,3,5-trien-1-yl]-2-methoxy-N-methylacetamide
C20H27NO3 — CID 163892781
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-[2-[(3,6-dimethylcyclohexa-1,3-dien-1-yl)oxymethyl]cyclohepta-1,3,5-trien-1-yl]-2-methoxy-N-methylacetamide
2-[2-[(3,6-dimethylcyclohexa-1,3-dien-1-yl)oxymethyl]cyclohepta-1,3,5-trien-1-yl]-2-methoxy-N-methylacetamide (PubChem CID 163892781) has the molecular formula C20H27NO3 and a molecular weight of 329.44 g/mol. Its IUPAC name is 2-[2-[(3,6-dimethylcyclohexa-1,3-dien-1-yl)oxymethyl]cyclohepta-1,3,5-trien-1-yl]-2-methoxy-N-methylacetamide.
Molecular Properties
| Compound Name | 2-[2-[(3,6-dimethylcyclohexa-1,3-dien-1-yl)oxymethyl]cyclohepta-1,3,5-trien-1-yl]-2-methoxy-N-methylacetamide |
|---|---|
| PubChem CID | 163892781 |
| Molecular Formula | C20H27NO3 |
| Molecular Weight | 329.44 g/mol |
| Exact Mass | 329.20 |
| IUPAC Name | 2-[2-[(3,6-dimethylcyclohexa-1,3-dien-1-yl)oxymethyl]cyclohepta-1,3,5-trien-1-yl]-2-methoxy-N-methylacetamide |
| SMILES | CNC(=O)C(OC)C1=C(COC2=CC(C)=CCC2C)C=CC=CC1 |
| InChI | InChI=1S/C20H27NO3/c1-14-10-11-15(2)18(12-14)24-13-16-8-6-5-7-9-17(16)19(23-4)20(22)21-3/h5-8,10,12,15,19H,9,11,13H2,1-4H3,(H,21,22) |
| InChIKey | QCZPRGGNEGOBSD-UHFFFAOYSA-N |
| XLogP | 3.45 |
| TPSA | 47.56 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 3 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 24 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 329.44 |
| LogP ≤ 5 | 3.45 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 3 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 163892781 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.